“Today, the FDA [fast track] issued an authorization for & nbsp; use in & nbsp; mdash conditions & nbsp; & nbsp; note TASS) molnupiravir [produced by the company] Merck for & nbsp; treatment of COVID-19 mild and & nbsp; moderate severity & raquo;, & nbsp; & mdash; said in & nbsp; the message.
Earlier, the American regulator approved for the & nbsp; emergency use of the drug for the & nbsp; treatment of COVID-19 Paxlovid, developed by Pfizer.